Keystone Wealth Services’s AbbVie ABBV Stock Holding History

Keystone Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$855K	Buy	3,399 +271	+9%	+$58.3K	0.16%	140
2026 Q1	$680K	Sell	3,128 -1,025	-25%	-$227K	0.15%	157
2025 Q4	$949K	Buy	4,153 +42	+1%	+$9.57K	0.2%	95
2025 Q3	$952K	Sell	4,111 -165	-4%	-$33.6K	0.21%	116
2025 Q2	$794K	Buy	4,276 +14	+0.3%	+$2.6K	0.19%	120
2025 Q1	$893K	Sell	4,262 -371	-8%	-$72.1K	0.24%	100
2024 Q4	$823K	Buy	4,633 +15	+0.3%	+$2.76K	0.22%	105
2024 Q3	$912K	Sell	4,618 -901	-16%	-$168K	0.25%	97
2024 Q2	$947K	Sell	5,519 -54	-1%	-$8.95K	0.29%	82
2024 Q1	$1.01M	Sell	5,573 -216	-4%	-$37.2K	0.33%	77
2023 Q4	$897K	Sell	5,789 -634	-10%	-$92.4K	0.31%	80
2023 Q3	$957K	Sell	6,423 -1,112	-15%	-$163K	0.36%	69
2023 Q2	$1.02M	Sell	7,535 -428	-5%	-$62.8K	0.38%	61
2023 Q1	$1.27M	Sell	7,963 -30	-0.4%	-$4.59K	0.52%	47
2022 Q4	$1.29M	Buy	7,993 +131	+2%	+$20.1K	0.56%	46
2022 Q3	$1.05M	Sell	7,862 -11	-0.1%	-$1.58K	0.5%	43
2022 Q2	$1.21M	Sell	7,873 -62	-0.8%	-$9.47K	0.54%	42
2022 Q1	$1.29M	Buy	7,935 +26	+0.3%	+$3.78K	0.51%	50
2021 Q4	$1.07M	Buy	+7,909	New	+$934K	0.43%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Keystone Wealth Services's ABBV Position: Q2 2026 in Review

Keystone Wealth Services increased its AbbVie (ABBV) stake by 8.7% in Q2 2026, buying an estimated $58.3K and bringing the position to 3,399 shares worth $855K. The position accounts for 0.16% of the portfolio, ranked #140.

Keystone Wealth Services first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.29M in Q4 2022. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Keystone Wealth Services held 3,399 shares of AbbVie worth $855K as of Q2 2026.
Keystone Wealth Services bought 271 AbbVie shares in Q2 2026, an estimated $58.3K.
AbbVie made up 0.16% of Keystone Wealth Services's portfolio in Q2 2026, its #140 holding.
Keystone Wealth Services first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Keystone Wealth Services's AbbVie position peaked at $1.29M in Q4 2022.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Keystone Wealth Services's 13F filing for Q2 2026, filed 5 Aug 2026.